ReviewCell cycle (Georgetown, Tex.)2018

A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.

Federica Sotgia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.